Protein-based oral tablet - Formulation IV

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Protein-based oral tablet - Formulation IV, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV [Phase 1]